Full Text
HPR5 Insight into Approvals, Marketing, and Pricing of New Medicines 2018 to 2022

Abstract

Authors

Blake Wladyka

Back to Volume 28, Supplemental Issue 6S1
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×